Akèy › Dematit atopik (Ekzema) › Missouri
Etid klinik pou Dematit atopik (Ekzema) nan Missouri
7 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan Missouri.
Tèks ofisyèl etid la (Anglè)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Red River Research Partners, Llc- Site Number : 8400054, Bolivar
- Cleaver Dermatology- Site Number : 8400033, Kirksville
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Saint Joseph
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06947993A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Saint Louis University, St Louis
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Sep 25, 2026 · NCT06807281Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- U.S. Dermatology Partners Lee's Summit, Lee's Summit
Ap rekriteEtid obsèvasyon
Laj 12 a 89 · Tout sèks · Mizajou Sep 15, 2026 · NCT07645820A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Washington University School of Medicine - St. Louis /ID# 268545, St Louis
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Aug 6, 2026 · NCT06461897A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- MediSearch Clinical Trials /ID# 263579, Saint Joseph
Ap rekriteFaz 3
Laj 18 a 63 · Tout sèks · Mizajou Jul 6, 2026 · NCT06389136Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7057, Lee's Summit
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06988605Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.